Drug Interactions With Phosphodiesterase-5 Inhibitors Used for the Treatment of Erectile Dysfunction or Pulmonary Hypertension

被引：85
|
作者：
Schwartz, Bryan G. [1 ]
Kloner, Robert A. [1 ,2 ]
机构：
[1] Hosp Good Samaritan, Inst Heart, Los Angeles, CA 90017 USA
[2] Univ So Calif, Keck Sch Med, Div Cardiovasc Med, Dept Internal Med, Los Angeles, CA 90033 USA
来源：
CIRCULATION | 2010年 / 122卷 / 01期
关键词：
drug combinations; nitroglycerin; pharmacokinetics; sex; vasodilation; HEALTHY MALE-SUBJECTS; INHALED NITRIC-OXIDE; ARTERIAL-HYPERTENSION; SILDENAFIL CITRATE; ORAL SILDENAFIL; CLINICAL-TRIALS; PHARMACOKINETIC INTERACTIONS; HEMODYNAMIC INTERACTION; CARDIOVASCULAR SAFETY; IN-VITRO;
D O I：
10.1161/CIRCULATIONAHA.110.944603
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：88 / 95
页数：8
相关论文
共 50 条
  • [31] Erectile dysfunction drug (phosphodiesterase-5 inhibitors) associated with non-arteritic anterior ischaemic optic neuropathy (NAION)
    不详
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 139 - 139
  • [32] Drug Insight:: oral phosphodiesterase type 5 inhibitors for erectile dysfunction
    Briganti, A
    Salonia, A
    Gallina, A
    Saccà, A
    Montorsi, P
    Rigatti, P
    Montorsi, F
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (05): : 239 - 247
  • [33] Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction
    Alberto Briganti
    Andrea Salonia
    Andrea Gallina
    Antonino Saccà
    Piero Montorsi
    Patrizio Rigatti
    Francesco Montorsi
    [J]. Nature Clinical Practice Urology, 2005, 2 : 239 - 247
  • [34] Erectile dysfunction and the role of phosphodiesterase-5 (PDE-5) inhibitors in schizophrenia. A brief review
    Dimopoulos, N. P.
    Mitsonis, C. I.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S111 - S112
  • [35] PHOSPHODIESTERASE-5 INHIBITORS FOR PULMONARY HYPERTENSION: A COCHRANE REVIEW - THE RESULTS FOR GROUP 1 PULMONARY ARTERIAL HYPERTENSION
    Brown, Z.
    Barnes, H.
    Williams, T.
    Burns, A.
    [J]. INTERNAL MEDICINE JOURNAL, 2018, 48 : 5 - 5
  • [36] Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction
    Francis, SH
    Corbin, JD
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2005, 32 (04) : 419 - +
  • [37] Phosphodiesterase type 5 inhibitors for erectile dysfunction
    Carson, CC
    Lue, TF
    [J]. BJU INTERNATIONAL, 2005, 96 (03) : 257 - 280
  • [38] Phosphodiesterase Type 5 Inhibitors and Erectile Dysfunction
    Whittaker, Catherine
    [J]. SA PHARMACEUTICAL JOURNAL, 2009, 76 (05) : 24 - 26
  • [39] Phosphodiesterase type 5 inhibitors and erectile dysfunction
    Whittaker, C.
    [J]. SOUTH AFRICAN FAMILY PRACTICE, 2010, 52 (03) : 207 - 210
  • [40] New phosphodiesterase inhibitors in the treatment of erectile dysfunction
    Anderson, PCB
    Gommersall, L
    Hayne, D
    Arya, M
    Patel, HRH
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (11) : 2241 - 2249
12345